|
|
||||||||
From the Department of Neurology (Drs. Wingerchuk, Hogancamp, and Weinshenker) and Health Sciences Research (Dr. OBrien), Mayo Clinic and Foundation, Rochester, MN.
Address correspondence and reprint requests to Dr. Brian G. Weinshenker, Dept. of Neurology, West 8A, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
OBJECTIVES: To evaluate the spectrum of neuromyelitis optica (NMO), including characteristics of the index events (optic neuritis [ON]) and myelitis), neuroimaging, CSF, and serologic studies, and to evaluate the long-term course.
METHODS: Review of 71 patients with NMO evaluated at the Mayo Clinic between 1950 and 1997.
RESULTS: NMO was either monophasic or relapsing. Patients with a monophasic course (n = 23) usually presented with rapidly sequential index events (median 5 days) with moderate recovery. Most with a relapsing course (n = 48) had an extended interval between index events (median 166 days) followed within 3 years by clusters of severe relapses isolated to the optic nerves and spinal cord. Most relapsing patients developed severe disability in a stepwise manner, and one-third died because of respiratory failure. Features of NMO distinct from "typical" MS included >50 cells/mm3 in CSF (often polymorphonuclear), normal initial brain MRI, and lesions extending over three or more vertebral segments on spinal cord MRI.
CONCLUSIONS: Clinical, laboratory, and imaging features generally distinguish neuromyelitis optica from MS. Patients with relapsing optic neuritis and myelitis may have neuromyelitis optica rather than MS. Patients with a relapsing course of neuromyelitis optica have a poor prognosis and frequently develop respiratory failure during attacks of cervical myelitis.
Key words: Neuromyelitis opticaDevics syndromePrognosisOptic neuritisMyelitisMS.
This article has been cited by other articles:
![]() |
L. A E Matthews, F. Baig, J. Palace, and M. R Turner The borderland of neuromyelitis optica Practical Neurology, December 1, 2009; 9(6): 335 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yanagawa, I. Kawachi, Y. Toyoshima, A. Yokoseki, M. Arakawa, A. Hasegawa, T. Ito, N. Kojima, R. Koike, K. Tanaka, et al. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis Neurology, November 17, 2009; 73(20): 1628 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
C-P Lo, H-W Kao, S-Y Chen, C-J Hsueh, W-C Lin, W-L Hsu, D-K Wu, and G-C Liu Prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis according to baseline MRI findings: comparison of revised McDonald criteria and Swanton modified criteria J. Neurol. Neurosurg. Psychiatry, October 1, 2009; 80(10): 1107 - 1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fazio, M. Malosio, V. Lampasona, D. De Feo, D. Privitera, F. Marnetto, D. Centonze, A. Ghezzi, G. Comi, R. Furlan, et al. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients Multiple Sclerosis, October 1, 2009; 15(10): 1153 - 1163. [Abstract] [PDF] |
||||
![]() |
S. Kim, P Waters, A Vincent, S. Kim, H. Kim, Y. Hong, K. Park, J. Min, J. Sung, and K. Lee Sjogren's syndrome myelopathy: spinal cord involvement in Sjogren's syndrome might be a manifestation of neuromyelitis optica Multiple Sclerosis, September 1, 2009; 15(9): 1062 - 1068. [Abstract] [PDF] |
||||
![]() |
A J Green and B A C Cree Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis J. Neurol. Neurosurg. Psychiatry, September 1, 2009; 80(9): 1002 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jacob, M. Matiello, B. G. Weinshenker, D. M. Wingerchuk, C. Lucchinetti, E. Shuster, J. Carter, B. M. Keegan, O. H. Kantarci, and S. J. Pittock Treatment of Neuromyelitis Optica With Mycophenolate Mofetil: Retrospective Analysis of 24 Patients Arch Neurol, September 1, 2009; 66(9): 1128 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nasir, D. A. Kerr, and J. Birnbaum Nineteen Episodes of Recurrent Myelitis in a Woman With Neuromyelitis Optica and Systemic Lupus Erythematosus Arch Neurol, September 1, 2009; 66(9): 1160 - 1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pellkofer, C Suessmair, A Schulze, R Hohlfeld, and T Kuempfel Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab Multiple Sclerosis, August 1, 2009; 15(8): 1006 - 1008. [Abstract] [PDF] |
||||
![]() |
T Matsushita, N Isobe, T Matsuoka, N Shi, Y Kawano, X. Wu, T Yoshiura, Y Nakao, T Ishizu, and J. Kira Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese Multiple Sclerosis, July 1, 2009; 15(7): 834 - 847. [Abstract] [PDF] |
||||
![]() |
J. Cabrera-Gomez, M Bonnan, A Gonzalez-Quevedo, A Saiz-Hinarejos, R Marignier, S Olindo, F Graus, D Smadja, H Merle, L Thomas, et al. Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies Multiple Sclerosis, July 1, 2009; 15(7): 828 - 833. [Abstract] [PDF] |
||||
![]() |
S Viegas, A Weir, M Esiri, W Kuker, P Waters, M I Leite, A Vincent, and J Palace Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica J. Neurol. Neurosurg. Psychiatry, June 1, 2009; 80(6): 679 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Nakamura, T Misu, K Fujihara, I Miyazawa, I Nakashima, T Takahashi, S Watanabe, and Y Itoyama Occurrence of acute large and edematous callosal lesions in neuromyelitis optica Multiple Sclerosis, June 1, 2009; 15(6): 695 - 700. [Abstract] [PDF] |
||||
![]() |
T Misu, R Takano, K Fujihara, T Takahashi, S Sato, and Y Itoyama Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker J. Neurol. Neurosurg. Psychiatry, May 1, 2009; 80(5): 575 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bichuetti, E. Oliveira, N. Souza, R. Rivero, and A. Gabbai Neuromyelitis optica in Brazil: a study on clinical and prognostic factors Multiple Sclerosis, May 1, 2009; 15(5): 613 - 619. [Abstract] [PDF] |
||||
![]() |
H Zephir, I Fajardy, O Outteryck, F Blanc, N Roger, M Fleury, G Rudolf, R Marignier, S Vukusic, C Confavreux, et al. Is neuromyelitis optica associated with human leukocyte antigen? Multiple Sclerosis, May 1, 2009; 15(5): 571 - 579. [Abstract] [PDF] |
||||
![]() |
M Bonnan, R Valentino, S Olindo, H Mehdaoui, D Smadja, and P Cabre Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder Multiple Sclerosis, April 1, 2009; 15(4): 487 - 492. [Abstract] [PDF] |
||||
![]() |
R. T. Naismith, N. T. Tutlam, J. Xu, E. C. Klawiter, J. Shepherd, K. Trinkaus, S. K. Song, and A. H. Cross Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis Neurology, March 24, 2009; 72(12): 1077 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. OSBORNE and N. J. VOLPE Optic neuritis and risk of MS: Differential diagnosis and management Cleveland Clinic Journal of Medicine, March 1, 2009; 76(3): 181 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Yiu, A. J. Kornberg, M. M. Ryan, L. T. Coleman, and M. T. Mackay Acute Transverse Myelitis and Acute Disseminated Encephalomyelitis in Childhood: Spectrum or Separate Entities? J Child Neurol, March 1, 2009; 24(3): 287 - 296. [Abstract] [PDF] |
||||
![]() |
H Doi, T Matsushita, N Isobe, T Matsuoka, M Minohara, H Ochi, and J. Kira Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody Multiple Sclerosis, March 1, 2009; 15(3): 304 - 310. [Abstract] [PDF] |
||||
![]() |
B. A. C. Cree, D. E. Reich, O. Khan, P. L. De Jager, I. Nakashima, T. Takahashi, A. Bar-Or, C. Tong, S. L. Hauser, and J. R. Oksenberg Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA Arch Neurol, February 1, 2009; 66(2): 226 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Osoegawa, J Kira, T Fukazawa, K Fujihara, S Kikuchi, M Matsui, T Kohriyama, G Sobue, T Yamamura, Y Itoyama, et al. Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years Multiple Sclerosis, February 1, 2009; 15(2): 159 - 173. [Abstract] [PDF] |
||||
![]() |
G. Alper and L. Wang Demyelinating Optic Neuritis in Children J Child Neurol, January 1, 2009; 24(1): 45 - 48. [Abstract] [PDF] |
||||
![]() |
M. B. Forrester, L. Coleman, and A. J. Kornberg Multiple Sclerosis in Childhood: Clinical and Radiological Features J Child Neurol, January 1, 2009; 24(1): 56 - 62. [Abstract] [PDF] |
||||
![]() |
D. Miller, B. Weinshenker, M Filippi, B. Banwell, J. Cohen, M. Freedman, S. Galetta, M Hutchinson, R. Johnson, L Kappos, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach Multiple Sclerosis, November 1, 2008; 14(9): 1157 - 1174. [Abstract] [PDF] |
||||
![]() |
S. Jarius, F. Aboul-Enein, P. Waters, B. Kuenz, A. Hauser, T. Berger, W. Lang, M. Reindl, A. Vincent, and W. Kristoferitsch Antibody to aquaporin-4 in the long-term course of neuromyelitis optica Brain, November 1, 2008; 131(11): 3072 - 3080. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jacob, B. G. Weinshenker, I. Violich, N. McLinskey, L. Krupp, R. J. Fox, D. M. Wingerchuk, M. Boggild, C. S. Constantinescu, A. Miller, et al. Treatment of Neuromyelitis Optica With Rituximab: Retrospective Analysis of 25 Patients Arch Neurol, November 1, 2008; 65(11): 1443 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Lotze, J. L. Northrop, G. J. Hutton, B. Ross, J. S. Schiffman, and J. V. Hunter Spectrum of Pediatric Neuromyelitis Optica Pediatrics, November 1, 2008; 122(5): e1039 - e1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Jarius, D Franciotta, R Bergamaschi, S Rauer, K P Wandinger, H F Petereit, M Maurer, H Tumani, A Vincent, P Eichhorn, et al. Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1134 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Merle, S. Olindo, A. Donnio, R. Richer, D. Smadja, and P. Cabre Retinal Peripapillary Nerve Fiber Layer Thickness in Neuromyelitis Optica Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4412 - 4417. [Abstract] [Full Text] [PDF] |
||||
![]() |
J-S Wu, M-N Zhang, W M Carroll, and A G Kermode Characterisation of the spectrum of demyelinating disease in Western Australia J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 1022 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Takahashi, I Miyazawa, T Misu, R Takano, I Nakashima, K Fujihara, M Tobita, and Y Itoyama Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 1075 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, et al. CNS aquaporin-4 autoimmunity in children Neurology, July 8, 2008; 71(2): 93 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okamoto, M. Ogawa, Youwei Lin, M. Murata, S. Miyake, and T. Yamamura Review: Treatment of neuromyelitis optica: Current debate Therapeutic Advances in Neurological Disorders, July 1, 2008; 1(1): 43 - 52. [Abstract] [PDF] |
||||
![]() |
P. Waters, S. Jarius, E. Littleton, M. I. Leite, S. Jacob, B. Gray, R. Geraldes, T. Vale, A. Jacob, J. Palace, et al. Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse Myelitis Arch Neurol, July 1, 2008; 65(7): 913 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. de Seze, F. Blanc, L. Jeanjean, H. Zephir, P. Labauge, M. Bouyon, L. Ballonzoli, G. Castelnovo, M. Fleury, S. Defoort, et al. Optical Coherence Tomography in Neuromyelitis Optica Arch Neurol, July 1, 2008; 65(7): 920 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Weinshenker Neuromyelitis Optica and Autoimmune Diseases--Reply Arch Neurol, July 1, 2008; 65(7): 996 - 996. [Full Text] [PDF] |
||||
![]() |
A Javed, R Balabanov, B. Arnason, T. Kelly, N. Sweiss, P Pytel, R Walsh, E. Blair, A Stemer, M Lazzaro, et al. Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis Multiple Sclerosis, July 1, 2008; 14(6): 809 - 814. [Abstract] [PDF] |
||||
![]() |
C. F. Lucchinetti, R. H. Gavrilova, I. Metz, J. E. Parisi, B. W. Scheithauer, S. Weigand, K. Thomsen, J. Mandrekar, A. Altintas, B. J. Erickson, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis Brain, July 1, 2008; 131(7): 1759 - 1775. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matiello, V. A. Lennon, A. Jacob, S. J. Pittock, C. F. Lucchinetti, D. M. Wingerchuk, and B. G. Weinshenker NMO-IgG predicts the outcome of recurrent optic neuritis Neurology, June 3, 2008; 70(23): 2197 - 2200. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Marignier, J. De Seze, S. Vukusic, F. Durand-Dubief, H. Zephir, P. Vermersch, P. Cabre, G. Cavillon, J. Honnorat, and C. Confavreux NMO-IgG and Devic's neuromyelitis optica: a French experience Multiple Sclerosis, May 1, 2008; 14(4): 440 - 445. [Abstract] [PDF] |
||||
![]() |
N Sofat and P J Venables Is Sjogren myelopathy Devic disease? Ann Rheum Dis, May 1, 2008; 67(5): 730 - 731. [Full Text] [PDF] |
||||
![]() |
T. Matsushita, T. Matsuoka, T. Ishizu, H. Kikuchi, M. Osoegawa, Y. Kawano, F. Mihara, Y. Ohyagi, and J.-i. Kira Anterior periventricular linear lesions in optic-spinal multiple sclerosis: a combined neuroimaging and neuropathological study Multiple Sclerosis, April 1, 2008; 14(3): 343 - 353. [Abstract] [PDF] |
||||
![]() |
L. R Mehta, M. K Samuelsson, A. K Kleiner, A. D Goodman, J. H Anolik, R J. Looney, and S. R Schwid Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome Multiple Sclerosis, April 1, 2008; 14(3): 425 - 427. [Abstract] [PDF] |
||||
![]() |
M. J. Dinkin, D. M. Cestari, M. C. Stein, S. D. Brass, and S. Lessell NMO Antibody-Positive Recurrent Optic Neuritis Without Clear Evidence of Transverse Myelitis Arch Ophthalmol, April 1, 2008; 126(4): 566 - 570. [Full Text] [PDF] |
||||
![]() |
R. A Wilcox, J. Burrow, M. Slee, J. Craig, and D. Thyagarajan Neuromyelitis optica (Devic's disease) in a patient with syphilis Multiple Sclerosis, March 1, 2008; 14(2): 268 - 271. [Abstract] [PDF] |
||||
![]() |
A Theodoridou and L Settas Demyelination in rheumatic diseases Postgrad. Med. J., March 1, 2008; 84(989): 127 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Levy, J. Birnbaum, and D. Kerr Finding NMO: Neuromyelitis optica in children Neurology, January 29, 2008; 70(5): 334 - 335. [Full Text] [PDF] |
||||
![]() |
B. Banwell, S. Tenembaum, V. A. Lennon, E. Ursell, J. Kennedy, A. Bar-Or, B. G. Weinshenker, C. F. Lucchinetti, and S. J. Pittock Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders Neurology, January 29, 2008; 70(5): 344 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Pittock, V. A. Lennon, J. de Seze, P. Vermersch, H. A. Homburger, D. M. Wingerchuk, C. F. Lucchinetti, H. Zephir, K. Moder, and B. G. Weinshenker Neuromyelitis Optica and Non Organ-Specific Autoimmunity Arch Neurol, January 1, 2008; 65(1): 78 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Blanc, H. Zephir, C. Lebrun, P. Labauge, G. Castelnovo, M. Fleury, F. Sellal, C. Tranchant, K. Dujardin, P. Vermersch, et al. Cognitive Functions in Neuromyelitis Optica Arch Neurol, January 1, 2008; 65(1): 84 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Papais-Alvarenga, S. C. Carellos, M. P. Alvarenga, C. Holander, R. P. Bichara, and L. C. S. Thuler Clinical Course of Optic Neuritis in Patients With Relapsing Neuromyelitis Optica Arch Ophthalmol, January 1, 2008; 126(1): 12 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Glisson and S. L. Galetta Is Neuromyelitis Optica Eyeing a Distinct Path From Multiple Sclerosis? Arch Ophthalmol, January 1, 2008; 126(1): 128 - 129. [Full Text] [PDF] |
||||
![]() |
S. R. Hinson, S. J. Pittock, C. F. Lucchinetti, S. F. Roemer, J. P. Fryer, T. J. Kryzer, and V. A. Lennon Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica Neurology, December 11, 2007; 69(24): 2221 - 2231. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Weinshenker, S. Galetta, J. Bennett, D. Kerr, and E. M. Frohman More on Multiple Sclerosis and Neuromyelitis Optica Reply Arch Neurol, December 1, 2007; 64(12): 1802 - 1803. [Full Text] [PDF] |
||||
![]() |
C. Yu, F. Lin, K. Li, T. Jiang, W. Qin, H. Sun, and P. Chan Pathogenesis of Normal-appearing White Matter Damage in Neuromyelitis Optica: Diffusion-Tensor MR Imaging Radiology, December 1, 2007; 246(1): 222 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yuksel, N. Senbil, D. Yilmaz, and Y.K. Yavuz Gurer Devic's Neuromyelitis Optica in an Infant Case J Child Neurol, September 1, 2007; 22(9): 1143 - 1146. [Abstract] [PDF] |
||||
![]() |
S. Watanabe, T. Misu, I. Miyazawa, I. Nakashima, Y. Shiga, K. Fujihara, and Y. Itoyama Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis Multiple Sclerosis, September 1, 2007; 13(8): 968 - 974. [Abstract] [PDF] |
||||
![]() |
K. Tanaka, T. Tani, M. Tanaka, T. Saida, J. Idezuka, M. Yamazaki, M. Tsujita, T. Nakada, K. Sakimura, and M. Nishizawa Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions Multiple Sclerosis, August 1, 2007; 13(7): 850 - 855. [Abstract] [PDF] |
||||
![]() |
C. S. Yu, C. Z. Zhu, K. C. Li, Y. Xuan, W. Qin, H. Sun, and P. Chan Relapsing Neuromyelitis Optica and Relapsing-Remitting Multiple Sclerosis: Differentiation at Diffusion-Tensor MR Imaging of Corpus Callosum Radiology, July 1, 2007; 244(1): 249 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Weinshenker Neuromyelitis Optica Is Distinct From Multiple Sclerosis Arch Neurol, June 1, 2007; 64(6): 899 - 901. [Full Text] [PDF] |
||||
![]() |
S. L. Galetta and J. Bennett Neuromyelitis Optica Is a Variant of Multiple Sclerosis Arch Neurol, June 1, 2007; 64(6): 901 - 903. [Full Text] [PDF] |
||||
![]() |
G.J.D. Hengstman, P. Wesseling, C.W.G.M. Frenken, and P.J.H. Jongen Neuromyelitis optica with clinical and histopathological involvement of the brain Multiple Sclerosis, June 1, 2007; 13(5): 679 - 682. [Abstract] [PDF] |
||||
![]() |
A. Compston Complexity and heterogeneity in demyelinating disease Brain, May 1, 2007; 130(5): 1178 - 1180. [Full Text] [PDF] |
||||
![]() |
S. F. Roemer, J. E. Parisi, V. A. Lennon, E. E. Benarroch, H. Lassmann, W. Bruck, R. N. Mandler, B. G. Weinshenker, S. J. Pittock, D. M. Wingerchuk, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis Brain, May 1, 2007; 130(5): 1194 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Misu, K. Fujihara, A. Kakita, H. Konno, M. Nakamura, S. Watanabe, T. Takahashi, I. Nakashima, H. Takahashi, and Y. Itoyama Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis Brain, May 1, 2007; 130(5): 1224 - 1234. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsuoka, T. Matsushita, Y. Kawano, M. Osoegawa, H. Ochi, T. Ishizu, M. Minohara, H. Kikuchi, F. Mihara, Y. Ohyagi, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese Brain, May 1, 2007; 130(5): 1206 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takahashi, K. Fujihara, I. Nakashima, T. Misu, I. Miyazawa, M. Nakamura, S. Watanabe, Y. Shiga, C. Kanaoka, J. Fujimori, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre Brain, May 1, 2007; 130(5): 1235 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Banwell The long (-itudinally extensive) and the short of it: Transverse myelitis in children Neurology, May 1, 2007; 68(18): 1447 - 1449. [Full Text] [PDF] |
||||
![]() |
J. M. Ness, D. Chabas, A. D. Sadovnick, D. Pohl, B. Banwell, B. Weinstock-Guttman, and for the International Pediatric MS Study Group Clinical features of children and adolescents with multiple sclerosis Neurology, April 17, 2007; 68(16_suppl_2): S37 - S45. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakamura, I. Nakashima, S. Sato, I. Miyazawa, K. Fujihara, and Y. Itoyama Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands Multiple Sclerosis, April 1, 2007; 13(3): 332 - 335. [Abstract] [PDF] |
||||
![]() |
J.A. Cabrera-Gomez, J. Galarraga-Inza, R.M. Coro-Antich, Y. Real-Gonzalez, M. Cristofol-Corominas, H. Gomez, K. Romero-Garcia, M.X. Gil-Gil, and A. Gonzalez-Quevedo Down's syndrome and neuromyelitis optica (Devic's disease). An autopsy-proven case Multiple Sclerosis, April 1, 2007; 13(3): 433 - 436. [Abstract] [PDF] |
||||
![]() |
S. Jarius, D. Franciotta, R. Bergamaschi, H. Wright, E. Littleton, J. Palace, R. Hohlfeld, and A. Vincent NMO-IgG in the diagnosis of neuromyelitis optica Neurology, March 27, 2007; 68(13): 1076 - 1077. [Full Text] [PDF] |
||||
![]() |
I. Miyazawa, I. Nakashima, A. Petzold, K. Fujihara, S. Sato, and Y. Itoyama High CSF neurofilament heavy chain levels in neuromyelitis optica Neurology, March 13, 2007; 68(11): 865 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Papeix, J-S Vidal, J de Seze, C Pierrot-Deseilligny, A Tourbah, B Stankoff, C Lebrun, T Moreau, P Vermersch, B Fontaine, et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica Multiple Sclerosis, March 1, 2007; 13(2): 256 - 259. [Abstract] [PDF] |
||||
![]() |
T Fukazawa and S Kikuchi A three-dimensional approach for understanding the spectrum of idiopathic inflammatory demyelinating disorders: importance of the 'attack-related severity' axis Multiple Sclerosis, March 1, 2007; 13(2): 199 - 207. [Abstract] [PDF] |
||||
![]() |
J. A Cabrera-Gomez, L Quevedo-Sotolongo, A Gonzalez-Quevedo, S Lima, Y Real-Gonzalez, M Cristofol-Corominas, K Romero-Garcia, C Ugarte-Sanchez, J Jordan-Gonzalez, J E G. de la Nuez, et al. Brain magnetic resonance imaging findings in relapsing neuromyelitis optica Multiple Sclerosis, March 1, 2007; 13(2): 186 - 192. [Abstract] [PDF] |
||||
![]() |
D. M. Wingerchuk, S. J. Pittock, C. F. Lucchinetti, V. A. Lennon, and B. G. Weinshenker A secondary progressive clinical course is uncommon in neuromyelitis optica Neurology, February 20, 2007; 68(8): 603 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Watanabe, I Nakashima, T Misu, I Miyazawa, Y Shiga, K Fujihara, and Y Itoyama Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica Multiple Sclerosis, January 1, 2007; 13(1): 128 - 132. [Abstract] [PDF] |
||||
![]() |
T. F. Scott, S. L. Kassab, and S. J. Pittock Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol, October 1, 2006; 63(10): 1398 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Petravic, M Habek, S Supe, and V V Brinar Recurrent optic neuromyelitis with endocrinopathies: a new syndrome or just a coincidence? Multiple Sclerosis, September 1, 2006; 12(5): 670 - 673. [Abstract] [PDF] |
||||
![]() |
I Nakashima, K Fujihara, I Miyazawa, T Misu, K Narikawa, M Nakamura, S Watanabe, T Takahashi, S Nishiyama, Y Shiga, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG J. Neurol. Neurosurg. Psychiatry, September 1, 2006; 77(9): 1073 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Giovannoni Neuromyelitis optica and anti-aquaporin-4 antibodies: widening the clinical phenotype J. Neurol. Neurosurg. Psychiatry, September 1, 2006; 77(9): 1001 - 1002. [Full Text] [PDF] |
||||
![]() |
M. Wilejto, M. Shroff, J. R. Buncic, J. Kennedy, C. Goia, and B. Banwell The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology, July 25, 2006; 67(2): 258 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Benedetti, P. Valsasina, E. Judica, V. Martinelli, A. Ghezzi, R. Capra, R. Bergamaschi, G. Comi, and M. Filippi Grading cervical cord damage in neuromyelitis optica and MS by diffusion tensor MRI. Neurology, July 11, 2006; 67(1): 161 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Weinstock-Guttman, M. Ramanathan, N. Lincoff, S. Q. Napoli, J. Sharma, J. Feichter, and R. Bakshi Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (devic disease). Arch Neurol, July 1, 2006; 63(7): 957 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Pittock, B. G. Weinshenker, C. F. Lucchinetti, D. M. Wingerchuk, J. R. Corboy, and V. A. Lennon Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol, July 1, 2006; 63(7): 964 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Falcini, S. Trapani, L. Ricci, M. Resti, G. Simonini, and M. de Martino Sustained improvement of a girl affected with Devic's disease over 2 years of mycophenolate mofetil treatment Rheumatology, July 1, 2006; 45(7): 913 - 915. [Full Text] [PDF] |
||||
![]() |
I. Kister, S. Gulati, C. Boz, R. Bergamaschi, G. Piccolo, J. Oger, and M. L. Swerdlow Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch Neurol, June 1, 2006; 63(6): 851 - 856. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |